Published in J Bone Miner Res on December 01, 1996
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96
Genetic susceptibility to lead poisoning. Environ Health Perspect (2000) 1.70
Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int (2010) 1.55
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect (2000) 1.35
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect (2000) 1.29
Bone mass acquisition in healthy children. Arch Dis Child (2005) 1.20
Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer (2001) 1.16
The role of genetic polymorphisms in environmental health. Environ Health Perspect (2003) 1.09
Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res (2007) 1.09
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther (2011) 1.07
Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect (2003) 1.03
Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis. Mol Biol Rep (2012) 0.96
Polymorphism in vitamin D receptor is associated with bone mineral density in patients with adolescent idiopathic scoliosis. Eur Spine J (2010) 0.95
Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: a meta-analysis. Nutr Res Pract (2011) 0.95
Maternal vitamin D receptor genetic variation contributes to infant birthweight among black mothers. Am J Med Genet A (2011) 0.95
Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: a preliminary report. Ann Rheum Dis (2000) 0.94
Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect (2003) 0.92
Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res (2001) 0.91
Vitamin D receptor alleles predict growth and bone density in girls. Arch Dis Child (1998) 0.90
Associations of bone mineral density and lead levels in blood, tibia, and patella in urban-dwelling women. Environ Health Perspect (2008) 0.89
Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases. Gut (2001) 0.88
The genetics of bone loss: challenges and prospects. J Clin Endocrinol Metab (2011) 0.88
Serum 25-hydroxyvitamin D and bone mineral density among Hispanic men. Osteoporos Int (2008) 0.86
Is osteoporosis a peculiar association with primary biliary cirrhosis? World J Gastroenterol (2005) 0.82
Epigenetic regulation of fetal bone development and placental transfer of nutrients: progress for osteoporosis. Interdiscip Toxicol (2011) 0.82
Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut (2005) 0.81
The implication of assessing a polymorphism in estrogen receptor alpha gene in the risk assessment of osteoporosis using a screening tool for osteoporosis in Asians. Osteoporos Int (2003) 0.80
Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderly. Calcif Tissue Int (2010) 0.80
Genetic studies of complex diseases: let the reader beware. J Bone Miner Res (1996) 0.78
Aging and the musculoskeletal system. Ann Rheum Dis (1997) 0.78
Genetics of pediatric bone strength. Bonekey Rep (2016) 0.78
Genetic and environmental factors affecting bone mineral density in large families. Postgrad Med J (1998) 0.78
Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. Lipids Health Dis (2014) 0.77
Association between vitamin D receptor polymorphisms and osteoporosis in patients with COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.77
Vitamin D receptor genotype and risk of osteoporotic hip fracture in elderly women of Utah: an effect modified by parity. Osteoporos Int (2006) 0.77
Influence of estrogen receptor α polymorphisms on bone density in response to habitual exercise in Japanese postmenopausal women. ScientificWorldJournal (2014) 0.77
The effect of FokI vitamin D receptor polymorphism on bone mineral density in Jordanian perimenopausal women. Indian J Hum Genet (2013) 0.77
Alveolar bone level is not associated with vitamin D receptor gene polymorphism and bone density in mandible. Clin Oral Investig (2011) 0.76
The Developmental Origins of Osteoporosis. Curr Genomics (2015) 0.75
Influence of BsmI polymorphism in vitamin D receptor gene on the risk of fracture in Caucasian populations: a meta analysis. Int J Clin Exp Med (2015) 0.75
Bone mineral density and gene-environment interactions in the search for osteoporosis genes. Environ Health Perspect (1999) 0.75
The genetics of response to estrogen treatment. Clin Cases Miner Bone Metab (2009) 0.75
Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study. PLoS One (2016) 0.75
Genetics of osteoarticular disorders, Florence, Italy, 22-23 February 2002. Arthritis Res (2002) 0.75
Association of oestrogen receptor gene polymorphism with the long-term results of rotational acetabular osteotomy. Int Orthop (2009) 0.75
Bone health, genetics, and personalised nutrition. Genes Nutr (2007) 0.75
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol (1994) 3.13
Using pooled exposure assessment to improve efficiency in case-control studies. Biometrics (1999) 2.51
XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (2000) 2.16
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90
Choosing a retrospective design to assess joint genetic and environmental contributions to risk. Am J Epidemiol (2000) 1.89
A hybrid design for studying genetic influences on risk of diseases with onset early in life. Am J Hum Genet (2005) 1.56
Imputation for exposure histories with gaps, under an excess relative risk model. Epidemiology (1996) 1.31
Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology (1999) 1.31
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.28
Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res (1995) 1.25
Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab (1995) 1.21
Pesticide use and adult-onset asthma among male farmers in the Agricultural Health Study. Eur Respir J (2009) 1.21
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res (1998) 1.20
Making the most of case-mother/control-mother studies. Am J Epidemiol (2008) 1.15
Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13
Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology (2000) 0.92
Animal production and wheeze in the Agricultural Health Study: interactions with atopy, asthma, and smoking. Occup Environ Med (2003) 0.91
Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators? Annu Rev Public Health (1999) 0.91
Vitamin D receptor polymorphisms and prostate cancer. Mol Carcinog (2000) 0.90
Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Can J Psychiatry (2001) 0.89
Calculation of population attributable risk for alcohol and breast cancer (United States). Cancer Causes Control (1999) 0.83
A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int J Cancer (2000) 0.82
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci (2011) 0.81
Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling and a comparison with normal boys. Hum Reprod (1997) 0.77
Age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol (1995) 0.76
Ontogeny of gonadotropin, testosterone, and inhibin secretion in normal boys through puberty based on overnight serial sampling. J Clin Endocrinol Metab (1995) 0.76
Two tests of association for a susceptibility locus for families of variable size: an example using two sampling strategies. Genet Epidemiol (1999) 0.75